| Line Item | 2026-05-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.19B | +14.9% | +47.9% |
| Cost of Revenue | $6.77B | +10.0% | +40.9% |
| Gross Profit | $15.41B | +17.2% | +51.2% |
| R&D Expense | $3.00B | +1.0% | +11.2% |
| SG&A Expense | $1.05B | +3.5% | -2.6% |
| Operating Income | $10.79B | +26.0% | +85.1% |
| Interest Expense | $776.0M |
| Line Item | 2026-05-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.63B | +38.5% | +107.2% |
| Accounts Receivable | $10.83B | +28.0% | +94.7% |
| Inventory | $4.33B | +46.1% | +114.6% |
| Current Assets | $42.21B | +31.7% | +90.3% |
| Total Assets | $179.16B | +5.4% | +8.8% |
| Current Liabilities |
| Line Item | 2026-05-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $18.75B | +127.0% | — |
| Capital Expenditures | $481.0M | +92.4% | — |
| Investing Cash Flow | -$323.0M | -180.9% | — |
| Financing Cash Flow | -$14.98B | -47.6% | — |
| Free Cash Flow | $18.27B | +128.1% | — |
| -3.1% |
| +0.9% |
| Pre-tax Income | $10.13B | +23.6% | +99.2% |
| Income Tax | $820.0M | -3.1% | +583.3% |
| Net Income | $9.31B | +26.7% | +87.5% |
| EPS (Basic) | $1.96 | +26.5% | +86.7% |
| EPS (Diluted) | $1.91 | +27.3% | +85.4% |
| $18.86B |
| +11.9% |
| -8.4% |
| Long-term Debt | $64.91B | -1.7% | +5.1% |
| Total Liabilities | $91.47B | +1.6% | -3.8% |
| Stockholders' Equity | $87.69B | +9.8% | +26.0% |